At this summit, during the two days of insightful case studies, participants will be given the opportunity to network with peers involved in pharmaceutical manufacturing, aseptic fill and finish, quality control, engineering, and container development.
Many more interesting and up-to-date topics will be included in this year’s program, so stay tuned and see you in November 2020!Read more
Vonlanthen Group is pleased to invite you to the 4th Annual Aseptic Processing Summit scheduled on November 19th – 20th, 2020 this time Online!
Virtual attendance of this event will provide you a broad overview of current changes in the European regulations, modern technical trends, emerging technologies and innovation in pharmaceutical manufacturing, aseptic fill and finish, quality control, engineering, and container development. Key topics in Aseptic Processing will be discussed by some of the industry’s leading lights.
We are excited to be hosting the 4th edition of 4th Annual Aseptic Processing Online Summit!
Chief Executives, Directors, Vice Presidents, Heads, Leaders, Senior Managers, Scientists, Chemists, Engineers and Fellows specialising in:
Johnson & Johnson
Richard Denk has studied mechanical engineering and did an examination on experts of GMP, qualification and validation, pharmaceutical auditing, pharmaceutical engineering, quality control at the University of Applied Sciences in Albstadt/Sigmaringen Germany. Richard works at SKAN AG, headquartered in Allschwil, as the head of sales containment. He founded the expert Containment Group of the ISPE DACH eight years ago. The Containment Group published the Containment Manual in September 2015. Richard has spent nearly 20 years working with highly active/highly hazardous substances and has developed the containment pyramid.
Walid El Azab is an industrial pharmacist, a qualified person and a Lean Six Sigma green belt. He is a technical services manager for STERIS Life Sciences. He provides technical support related to cleaning, disinfectants, sterility assurance and process validation. Finally, he leads audits at manufacturer sites and workshops to improve processes and inspection readiness level. Walid is a lecturer at a pharmacy and medicine university. He has published different articles and book chapters, and he is also part of working groups on sterilisation and EU GMP Annex 1 guideline revision. He is a planning committee member of the Annual PDA Conference on Pharmaceutical Microbiology (12th and 13th editions), and part of the editorial committee of the PDA Letter. Walid is an observer member of the ISPE Belgium affiliate board. Finally, he is secretary of the Belgium Qualified Person Association.
Dr. Mauro Giusti holds a Master's Degree in Chemistry at the University of Florence and he is Board Certified by National Chemist association.
After completion of mandatory military service as an Army officer, he joined Eli Lilly at the Italy manufacturing plant site in 1988. Over the 32 years with Eli Lilly, Dr. Giusti has covered several positions within the Lilly Manufacturing organization (Regulatory, Technical Services, Project Management, Quality Control, Quality Assurance, Production of oral and parenteral products, Technical Director/Qualified Person, Six Sigma Champion. Manufacturing Science and Technology, Manufacturing Procurement), dealing both with Lilly manufacturing plants as well as with Contract manufacturing in the Europe/Africa/Asia.
Among the several experiences with Lilly, he has worked approximately 5 years outside of Italy, both in United States (2.5 yrs, from 1992 to 1994) and in United Kingdom (2.5 yrs, from 1997 to 1999).
Since late 2003, with the Lilly Italia mission change from Sterile and Oral cephalosporin to Biotech products, he has had responsibility for Lilly Italy TSMS (Technical Svcs/Mfg Science Department), with responsibility for Metrology, C&Q of facilities, utilities, and equipment, Sterility Assurance, Process Validation, set-up of new manufacturing processes and of new manufacturing technology for Biotech products, including automatic assembly of disposable Ins. pens and Autoinjectors. In September 2009 he also added to his TSMS duties, the responsibility for Manufacturing Sourcing and Vendor Management.
In September 2019 he has taken a new role, as Advisor, Site External Network, dealing with external entities linked to the Lilly Sesto Manufacturing site (especially Universities) and leading a Lilly Global project for improvement of technical capabilities in Parenteral Manufacturing.
For more than 12 years he has served as a member of the Italy Chapter of PDA, with several participations to national and international forum both as a speaker and as chairman.
Mrs. Vinnerås has been with Fresenius Kabi since 2017, and previous to that since 2000 she worked for pharmaceutical and medical device companies such as Abbott and Pfizer within different quality departments and holding various management responsibilities and positions. Recently, as an associated senior quality consultant at ÅF Life Science, she had assignments within the areas of quality assurance, risk management, validation and education at clients such as GE Healthcare, Thermo Fisher Scientific, Fresenius Kabi and smaller life science companies. Currently, Henrietta is part of a global competence center within Fresenius Kabi, supporting the companys’ pharmaceutical manufacturing operations worldwide by establishing global corporate procedures, performing on-site assessments, education and training, trouble shooting, root cause investigations, CAPAs and continuous improvement projects; specifically within the areas of microbiology and aseptic technique.
Thomas Schwarz has a PhD in chemistry and an executive MBA. He joined Aventis in 1999 in Frankfurt, where he worked in recombinant insulin production. He has worked at Novartis since 2006 in a variety of functions including process manager of sterile manufacturing, plant manager of biotech in the US and QA/QV team leader. He is currently the head of strategic planning for aseptics, which includes nine drug product sites around the globe.
Johnson & Johnson
Principal Scientist for Parenteral Process Development in Pharmaceutical Technologies at Merck Healthcare KGaA in Darmstadt, Germany.
Robert is a pharmacist by training and holds a PhD in Pharmaceutical Technology from the Ludwig-Maximilians University in Munich, Germany. At the LMU he gained profound knowledge in the field of formulation development of therapeutic protein-polymer conjugates. He joined the pharmaceutical industry in 2014 as a compliance expert at Sanofi-Aventis Deutschland GmbH (Frankfurt am Main, Germany) and was responsible for the industrialization of parenteral late stage projects as well as process optimization of marketed parenteral products. In 2017, he joined the Merck Healthcare KGaA (Darmstadt, Germany) in the role of a principal scientist for parenteral DP development. Additionally, he represents the head of manufacturing for the construction of a novel high containment GMP pilot plant for sterile DP manufacturing where cutting-edge single-use technology as well as latest regulatory expectations will be implemented.
Matthias Angelmaier has a bachelor’s degree in industrial and mechanical engineering as well as a master’s degree in business development. He joined Syntegon Technology GmbH in 2009. During his first 3 years, he was a project manager for handling complex customer projects. Since 2012, he is the globally responsible product manager for barrier systems, isolator and process technology. His expertise includes process engineering, sterilization, bio-decontamination, aseptic and high-potent Isolator applications, glove testing systems as well as topics related to advanced aseptic processing. He is a frequent speaker on international symposia and conferences including organizations like ISPE and PDA
Dr. Lee is responsible for product and business development along with providing strategic direction. Before joining LLS Health, Rob held senior management positions at Novavax, Inc., Lyotropic Therapeutics, Inc., and Imcor Pharmaceutical Co. He holds BSs in Biology and Chemistry from the University of Washington and a PhD in Physical Bioorganic Chemistry from the University of California, Santa Barbara. Rob has published more than three dozen articles and five book chapters plus holds 11 issued patents and 15 provisional or PCT patent applications. He has over 30 years of experience in pharmaceutical research and development of both therapeutic drugs and diagnostic imaging agents. Rob maintains strong academic ties, including an appointment as Adjunct Associate Professor of Pharmaceutical Chemistry at the University of Kansas in the early 1990s, serving as a reviewer for both the International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences, and serving on the Editorial Board for the Journal MOJ Bioequivalence & Bioavailability, The Scientific Pages of Nanotechnology, and The Journal of Analytical and Pharmaceutical Research.
Sebastian Scheler (born 1987) is a qualified psychologist and expert trainer. As CEO and Lead Psychologist (since 2017) at Innerspace - The DeepTraining Company, he is not only responsible for company management moreover for the global business development and implementation of deep training products in the pharmaceutical industry. As an expert in training transfer and human error analysis, he is also a speaker at various specialist events.
Johnson & Johnson
Request the 4th Annual Aseptic Processing Summit recording, and find out the latest topics and ideas that were shared during the event.
Please fill in your e-mail address below and we will process your request in a moment.
"Great speakers & exemplary knowledge sharing across the industry!"
"I ( and many others from the conference) think this is the best European conference on Aseptic Filling technology. Very interesting conference"
"It was a pleasure to give a speech at the 3rd Annual Aseptic Processing Summit in Vienna! Great exchange of expertise and very wide networking across Pharma & Biopharma Companies. Thanks to you for the invitation!"
"It was a great conference; great information sharing across all groups. Over 100 people."
"Thank you Dana and the rest of the Vonlanthen team for a well-organized summit in Vienna – and an extended thank you to all speakers and participants for all the good discussions and networking during the two days we had together!"
Thank you for your interest!
Nov 20, 2019
3rd Annual Aseptic Processing Summit